Defence Therapeutics (STU:DTC) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:DTC Defence Therapeutics Inc STU:DTC
30 GF Score
Price €0.26
! 1 Warning Sign
View Full Analysis

What is Defence Therapeutics FFO per Share?

FFO per Share only applies to REITs.

STU:DTC
30GF Score
Defence Therapeutics Inc STU:DTC
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Defence Therapeutics Business Description

Other Exchanges DTCFF:USADTC:Canada
Address 7171 Frederick Banting Street, Montreal, QC, CAN, H4S 1Z9
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.
30GF Score

Get the complete analysis for STU:DTC

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price